SCHOTT Pharma AG & Co. KGaA (FRA:1SXP)

Market Cap	3.16B
Revenue (ttm)	975.68M
Net Income (ttm)	146.87M
Shares Out	n/a
EPS (ttm)	0.97
PE Ratio	21.53
Forward PE	19.10
Dividend	0.16 (0.76%)
Ex-Dividend Date	Feb 5, 2025

Volume	330
Average Volume	57,836
Open	21.05
Previous Close	21.00
Day's Range	21.05 - 21.15
52-Week Range	18.50 - 32.74
Beta	n/a
RSI	40.74
Earnings Date	Dec 11, 2025

About FRA:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide. The company offers prefillable glass or polymer syringes, glass vials, cartridges, and ampoules. Its syringe products include syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPA...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1884
• Employees: 4,690
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1SXP

Financial Performance

In 2024, FRA:1SXP's revenue was 957.09 million, an increase of 6.51% compared to the previous year's 898.60 million. Earnings were 149.69 million, a decrease of -1.42%.